Anti Malarial Drugs Market by Drug Type, Malaria Type, Mechanism of Action, Distribution Channel and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2030

4.3%
CAGR (2024-2030)
992.87 USD Mn.
Market Size
303
Report Pages
154
Market Tables

Overview

Anti Malarial Drugs Market is expected to grow at a CAGR of 4.3% during the forecast period and market is expected to reach US$ 1333.16 Mn. by 2030.

Anti-malarial drugs are the medicines used to prevent as well as treat malaria. They are also used for avoidance of infection in individuals who travel to malaria-endemic regions. Malaria is a life-threatening disease caused by parasites that are spread toward people through the bites of infected female Anopheles mosquitoes. Malaria is preventable and curable. Anti-malarial medicines are available in the market in the form of tablet, injectables, and capsules.

Anti Malarial Drugs MarketTo know about the Research Methodology:- Request Free Sample Report

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

The strong initiatives taken by the various state governments and governing bodies such as U.S. food and drug administration (FDA) to reduce the occurrence of malarial disease throughout the world, also estimated to fuel the demand for the anti-malarial drugs market. Availability of key players, and better R&D facilities & reimbursement policies are the major factors driving the growth of the global anti-malarial drugs market. However, the possible side effects of anti-malarial drugs like insomnia, vivid dreams, mental clouding, dizziness, and anxiety may hinder the growth of the global anti-malarial drugs market.

Malaria is considered as a most terrible disease because it causes of death due to lack of availability of the anti-malarial drugs which has become the key opportunity for the growth of the anti-malarial drugs market during the forecast period.

There are four major drugs, which currently used to treat malaria include quinoline-related compounds, antifolates, artemisinin derivatives, and antimicrobials. Quinine is a medicine used to treat malaria and babesiosis. Quinine contains the treatment of malaria, owing to Plasmodium falciparum that is resistant to chloroquine when artesunate is not available. Artemisinin is used to reduce the number of Plasmodium parasites in the blood of patients with malaria. Some side effects of artemisinin include skin rash, nausea, vomiting, tremors, and liver issues.

Plasmodium falciparum and Plasmodium vivax are the most dangerous types of malaria. Plasmodium falciparum is the most common malaria parasite in South Africa, and it causes the most malaria-related deaths in the world. Plasmodium falciparum multiplies very quickly and causing severe blood loss as well as clogged blood vessels. Plasmodium vivax is mostly found in the Asia Pacific. Plasmodium vivax infects 19-50 million people with malaria every year.

Asia-Pacific is the most lucrative region for the anti-malarial drugs, owing to the higher incidence of the malarial diseases in the region and thus is expected to show a robust growth to the global anti-malarial drugs market. The Asia Pacific is account for the highest market share of 30.2% during the forecast period in the anti-malarial drugs market. China & India are the major providers to the growth of Asia Pacific anti-malarial drugs market.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global anti-malarial drugs market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence.

The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in anti-malarial drugs market.

Anti-Malarial Drugs Market Scope: Inquire before buying

Global Anti-Malarial Drugs Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 992.87 Mn.
Forecast Period 2024 to 2030 CAGR: 4.3% Market Size in 2030: US $ 1333.16 Mn.
Segments Covered: by Drug Type Quinine
Chloroquine
Amodiaquine
Pyrimethamine
Others
by Malaria Type Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
by Mechanism of Action Resistance
Prevention
by Distribution Channel Hospitals & Retail Pharmacy
E-Commerce
Others

Global Anti-Malarial Drugs Market, by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

The Key Players Operating In the Global Anti-Malarial Drugs Market:

1. Mylan Labs
2. Cipla
3. GlaxoSmithKline
4. Novartis
5. Roche
6. Bayer AG
7. Lincoln Pharmaceuticals
8. Strides Pharma Science
9. Glenmark Pharmaceuticals
10.Alliance Pharmaceuticals
11.F. Hoffmann-La Roche AG
12.Alvizia Healthcare Pvt. Ltd.
13.Ipca Laboratories Ltd.
14.Merck & Co., Inc
15.Sun Pharmaceutical Industries Ltd.
16.Zydus Cadila.
17.Ranbaxy Laboratories

Frequently Asked Questions:

1. Which region has the largest share in Global Anti-Malarial Drugs Market?
Ans: Asia Pacific region holds the highest share in 2023.

2. What is the growth rate of Global Anti-Malarial Drugs Market?
Ans: The Global Anti-Malarial Drugs Market is growing at a CAGR of 4.3% during forecasting period 2024-2030.

3. What is scope of the Global Anti-Malarial Drugs market report?
Ans: Global Anti-Malarial Drugs Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Anti-Malarial Drugs market?
Ans: The important key players in the Global Anti-Malarial Drugs Market are – Mylan Labs, Cipla, GlaxoSmithKline, Novartis, Roche, Bayer AG, Lincoln Pharmaceuticals, Strides Pharma Science, Glenmark Pharmaceuticals, Alliance Pharmaceuticals, F. Hoffmann-La Roche AG, Alvizia Healthcare Pvt. Ltd., Ipca Laboratories Ltd., Merck & Co., Inc, Sun Pharmaceutical Industries Ltd., Zydus Cadila., and Ranbaxy Laboratories.

5. What is the study period of this market?
Ans: The Global Anti-Malarial Drugs Market is studied from 2023 to 2030.

Table of Contents

1. Anti-Malarial Drugs Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Anti-Malarial Drugs Market: Dynamics 2.1. Anti-Malarial Drugs Market Trends by Region 2.1.1. North America Anti-Malarial Drugs Market Trends 2.1.2. Europe Anti-Malarial Drugs Market Trends 2.1.3. Asia Pacific Anti-Malarial Drugs Market Trends 2.1.4. Middle East and Africa Anti-Malarial Drugs Market Trends 2.1.5. South America Anti-Malarial Drugs Market Trends 2.2. Anti-Malarial Drugs Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Anti-Malarial Drugs Market Drivers 2.2.1.2. North America Anti-Malarial Drugs Market Restraints 2.2.1.3. North America Anti-Malarial Drugs Market Opportunities 2.2.1.4. North America Anti-Malarial Drugs Market Challenges 2.2.2. Europe 2.2.2.1. Europe Anti-Malarial Drugs Market Drivers 2.2.2.2. Europe Anti-Malarial Drugs Market Restraints 2.2.2.3. Europe Anti-Malarial Drugs Market Opportunities 2.2.2.4. Europe Anti-Malarial Drugs Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Anti-Malarial Drugs Market Drivers 2.2.3.2. Asia Pacific Anti-Malarial Drugs Market Restraints 2.2.3.3. Asia Pacific Anti-Malarial Drugs Market Opportunities 2.2.3.4. Asia Pacific Anti-Malarial Drugs Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Anti-Malarial Drugs Market Drivers 2.2.4.2. Middle East and Africa Anti-Malarial Drugs Market Restraints 2.2.4.3. Middle East and Africa Anti-Malarial Drugs Market Opportunities 2.2.4.4. Middle East and Africa Anti-Malarial Drugs Market Challenges 2.2.5. South America 2.2.5.1. South America Anti-Malarial Drugs Market Drivers 2.2.5.2. South America Anti-Malarial Drugs Market Restraints 2.2.5.3. South America Anti-Malarial Drugs Market Opportunities 2.2.5.4. South America Anti-Malarial Drugs Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Anti-Malarial Drugs Industry 2.8. Analysis of Government Schemes and Initiatives For Anti-Malarial Drugs Industry 2.9. Anti-Malarial Drugs Market Trade Analysis 2.10. The Global Pandemic Impact on Anti-Malarial Drugs Market 3. Anti-Malarial Drugs Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 3.1.1. Quinine 3.1.2. Chloroquine 3.1.3. Amodiaquine 3.1.4. Pyrimethamine 3.1.5. Others 3.2. Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 3.2.1. Plasmodium Falciparum 3.2.2. Plasmodium Vivax 3.2.3. Plasmodium Malariae 3.2.4. Plasmodium Ovale 3.3. Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 3.3.1. Resistance 3.3.2. Prevention 3.4. Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 3.4.1. Hospitals & Retail Pharmacy 3.4.2. E-Commerce 3.4.3. Others 3.5. Anti-Malarial Drugs Market Size and Forecast, by Region (2023-2030) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Anti-Malarial Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 4.1.1. Quinine 4.1.2. Chloroquine 4.1.3. Amodiaquine 4.1.4. Pyrimethamine 4.1.5. Others 4.2. North America Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 4.2.1. Plasmodium Falciparum 4.2.2. Plasmodium Vivax 4.2.3. Plasmodium Malariae 4.2.4. Plasmodium Ovale 4.3. North America Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 4.3.1. Resistance 4.3.2. Prevention 4.4. North America Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 4.4.1. Hospitals & Retail Pharmacy 4.4.2. E-Commerce 4.4.3. Others 4.5. North America Anti-Malarial Drugs Market Size and Forecast, by Country (2023-2030) 4.5.1. United States 4.5.1.1. United States Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 4.5.1.1.1. Quinine 4.5.1.1.2. Chloroquine 4.5.1.1.3. Amodiaquine 4.5.1.1.4. Pyrimethamine 4.5.1.1.5. Others 4.5.1.2. United States Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 4.5.1.2.1. Plasmodium Falciparum 4.5.1.2.2. Plasmodium Vivax 4.5.1.2.3. Plasmodium Malariae 4.5.1.2.4. Plasmodium Ovale 4.5.1.3. United States Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 4.5.1.3.1. Resistance 4.5.1.3.2. Prevention 4.5.1.4. United States Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 4.5.1.4.1. Hospitals & Retail Pharmacy 4.5.1.4.2. E-Commerce 4.5.1.4.3. Others 4.5.2. Canada 4.5.2.1. Canada Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 4.5.2.1.1. Quinine 4.5.2.1.2. Chloroquine 4.5.2.1.3. Amodiaquine 4.5.2.1.4. Pyrimethamine 4.5.2.1.5. Others 4.5.2.2. Canada Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 4.5.2.2.1. Plasmodium Falciparum 4.5.2.2.2. Plasmodium Vivax 4.5.2.2.3. Plasmodium Malariae 4.5.2.2.4. Plasmodium Ovale 4.5.2.3. Canada Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 4.5.2.3.1. Resistance 4.5.2.3.2. Prevention 4.5.2.4. Canada Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 4.5.2.4.1. Hospitals & Retail Pharmacy 4.5.2.4.2. E-Commerce 4.5.2.4.3. Others 4.5.3. Mexico 4.5.3.1. Mexico Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 4.5.3.1.1. Quinine 4.5.3.1.2. Chloroquine 4.5.3.1.3. Amodiaquine 4.5.3.1.4. Pyrimethamine 4.5.3.1.5. Others 4.5.3.2. Mexico Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 4.5.3.2.1. Plasmodium Falciparum 4.5.3.2.2. Plasmodium Vivax 4.5.3.2.3. Plasmodium Malariae 4.5.3.2.4. Plasmodium Ovale 4.5.3.3. Mexico Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 4.5.3.3.1. Resistance 4.5.3.3.2. Prevention 4.5.3.4. Mexico Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 4.5.3.4.1. Hospitals & Retail Pharmacy 4.5.3.4.2. E-Commerce 4.5.3.4.3. Others 5. Europe Anti-Malarial Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.2. Europe Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.3. Europe Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 5.4. Europe Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5. Europe Anti-Malarial Drugs Market Size and Forecast, by Country (2023-2030) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.1.2. United Kingdom Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.1.3. United Kingdom Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action(2023-2030) 5.5.1.4. United Kingdom Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.2. France 5.5.2.1. France Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.2.2. France Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.2.3. France Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action(2023-2030) 5.5.2.4. France Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.3. Germany 5.5.3.1. Germany Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.3.2. Germany Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.3.3. Germany Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 5.5.3.4. Germany Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.4. Italy 5.5.4.1. Italy Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.4.2. Italy Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.4.3. Italy Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action(2023-2030) 5.5.4.4. Italy Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.5. Spain 5.5.5.1. Spain Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.5.2. Spain Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.5.3. Spain Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 5.5.5.4. Spain Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.6. Sweden 5.5.6.1. Sweden Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.6.2. Sweden Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.6.3. Sweden Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 5.5.6.4. Sweden Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.7. Austria 5.5.7.1. Austria Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.7.2. Austria Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.7.3. Austria Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 5.5.7.4. Austria Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 5.5.8.2. Rest of Europe Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 5.5.8.3. Rest of Europe Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 5.5.8.4. Rest of Europe Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6. Asia Pacific Anti-Malarial Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.2. Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.3. Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.4. Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5. Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Country (2023-2030) 6.7.1. China 6.5.1.1. China Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.1.2. China Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.1.3. China Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.1.4. China Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.2. S Korea 6.5.2.1. S Korea Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.2.2. S Korea Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.2.3. S Korea Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.2.4. S Korea Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.3. Japan 6.5.3.1. Japan Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.3.2. Japan Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.3.3. Japan Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.3.4. Japan Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.4. India 6.5.4.1. India Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.4.2. India Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.4.3. India Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.4.4. India Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.5. Australia 6.5.5.1. Australia Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.5.2. Australia Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.5.3. Australia Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.5.4. Australia Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.6. Indonesia 6.5.6.1. Indonesia Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.6.2. Indonesia Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.6.3. Indonesia Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.6.4. Indonesia Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.7. Malaysia 6.5.7.1. Malaysia Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.7.2. Malaysia Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.7.3. Malaysia Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.7.4. Malaysia Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.8. Vietnam 6.5.8.1. Vietnam Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.8.2. Vietnam Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.8.3. Vietnam Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action(2023-2030) 6.5.8.4. Vietnam Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.9. Taiwan 6.5.9.1. Taiwan Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.9.2. Taiwan Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.9.3. Taiwan Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.9.4. Taiwan Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 6.5.10.2. Rest of Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 6.5.10.3. Rest of Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 6.5.10.4. Rest of Asia Pacific Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 7. Middle East and Africa Anti-Malarial Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 7.2. Middle East and Africa Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 7.3. Middle East and Africa Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 7.4. Middle East and Africa Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 7.5. Middle East and Africa Anti-Malarial Drugs Market Size and Forecast, by Country (2023-2030) 7.5.1. South Africa 7.5.1.1. South Africa Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 7.5.1.2. South Africa Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 7.5.1.3. South Africa Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 7.5.1.4. South Africa Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.2. GCC 7.5.2.1. GCC Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 7.5.2.2. GCC Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 7.5.2.3. GCC Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 7.5.2.4. GCC Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.3. Nigeria 7.5.3.1. Nigeria Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 7.5.3.2. Nigeria Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 7.5.3.3. Nigeria Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 7.5.3.4. Nigeria Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 7.5.4.2. Rest of ME&A Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 7.5.4.3. Rest of ME&A Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 7.5.4.4. Rest of ME&A Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 8. South America Anti-Malarial Drugs Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 8.2. South America Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 8.3. South America Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action(2023-2030) 8.4. South America Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 8.5. South America Anti-Malarial Drugs Market Size and Forecast, by Country (2023-2030) 8.5.1. Brazil 8.5.1.1. Brazil Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 8.5.1.2. Brazil Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 8.5.1.3. Brazil Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 8.5.1.4. Brazil Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 8.5.2. Argentina 8.5.2.1. Argentina Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 8.5.2.2. Argentina Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 8.5.2.3. Argentina Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 8.5.2.4. Argentina Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Anti-Malarial Drugs Market Size and Forecast, by Drug Type (2023-2030) 8.5.3.2. Rest Of South America Anti-Malarial Drugs Market Size and Forecast, by Malaria Type (2023-2030) 8.5.3.3. Rest Of South America Anti-Malarial Drugs Market Size and Forecast, by Mechanism of Action (2023-2030) 8.5.3.4. Rest Of South America Anti-Malarial Drugs Market Size and Forecast, by Distribution Channel (2023-2030) 9. Global Anti-Malarial Drugs Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Anti-Malarial Drugs Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Mylan Labs 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Cipla 10.3. GlaxoSmithKline 10.4. Novartis 10.5. Roche 10.6. Bayer AG 10.7. Lincoln Pharmaceuticals 10.8. Strides Pharma Science 10.9. Glenmark Pharmaceuticals 10.10. Alliance Pharmaceuticals 10.11. F. Hoffmann-La Roche AG 10.12. Alvizia Healthcare Pvt. Ltd. 10.13. Ipca Laboratories Ltd. 10.14. Merck & Co., Inc 10.15. Sun Pharmaceutical Industries Ltd. 10.16. Zydus Cadila. 10.17. Ranbaxy Laboratories 11. Key Findings 12. Industry Recommendations 13. Anti-Malarial Drugs Market: Research Methodology 14. Terms and Glossary

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Request Customization Download Sample